RNS Number : 3004O Conviction Life Sciences Company 30 January 2023 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL. PLEASE SEE THE SECTION ENTITLED "IMPORTANT NOTICES" TOWARDS THE END OF THIS ANNOUNCEMENT. LEI Number: 984500E67FC2F039E894 Convicon Life Sciences Company Limited ("CLSC" or the "Company") Update on IPO Further to the publicaon of the prospectus on 16 November 2022 (the "Prospectus"), the Company has decided not to proceed with its inial public offering ("IPO") due to current market uncertainty. The Board has been encouraged by the interest shown to date, reflecng the Board's opinion of the compelling fundamental characteriscs of the proposion. However, market condions connue to be challenging and the Board, in consultaon with the Investment Manager, has made this decision in light of the current outlook. Any subscripon monies received via the Intermediaries Offer or the Offer for Subscripon will be returned to investors within 10 Business Days. Terms used and not defined in this announcement bear the meaning given to them in the Prospectus. For further enquiries please contact Plain English Finance - Investment Manager Andrew Craig, Roderick Collins, Dr Luke Zhou +44 (0) 20 3884 9955 clsc@plainenglishfinance.com Shore Capital - Sponsor, Bookrunner and Intermediaries Offer Adviser Robert Finlay, Rose Ramsden, Angus Murphy (Corporate Finance) Henry Willcocks, Fiona Conroy (Corporate Broking) Ellio Shaw (Sales) +44 (0) 20 7408 4090 Neville Registrars - Receiving Agent for the Offer for Subscripon Mark Hickman 44 (0) 121 585 1131 info@nevilleregistars.co.uk SEC Newgate - PR Adviser Elisabeth Cowell George Esmond +44 (0) 20 3757 6882 ConviconLifeSciences@secnewgate.co.uk IMPORTANT NOTICES Each of Shore Capital & Corporate Limited (the "Sponsor") and Shore Capital Stockbrokers Limited (the "Placing Agent") is authorised and regulated in the United Kingdom by the FCA. References in this document to "Shore Capital" are references to either the Sponsor or the Placing Agent or both of them, as appropriate. Shore Capital is acng exclusively for the

Company and for no-one else in connecon with the maers described in this announcement and will not be responsible to anyone other than the Company for providing the protecons afforded to the clients of Shore Capital, nor for providing advice in relaon to any of the maers referred to in this announcement. The Ordinary Shares have not been and will not be registered under the United States Securies Act of 1933 (as amended) (the "US Securies Act") or with any securies regulatory authority of any state or other jurisdicon of the United States, and may not be offered or sold within the United States or to, or for the account or benefit of, US Persons (as defined in Regulaon S under the US Securies Act ("Regulaon S")), except pursuant to an exempon from, or in a transacon not subject to, the registraon requirements of the US Securies Act and in compliance with any applicable securies laws of any state or other jurisdicon in the United States. In addion, the Company has not been and will not be registered under the United States Investment Company Act of 1940, (as amended) (the "US Investment Company Act"), and recipients of the Prospectus will not be entled to the benefits of that Act. This announcement is not for publicaon or distribuon, directly or indirectly, in or into the United States of America. This announcement is not an offer of securies for sale into the United States. No public offering of securies is being made in the United States. The offer and sale of Ordinary Shares has not been and will not be registered under the applicable securies laws of any Member State of the EEA, Canada, Japan or the Republic of South Africa. Subject to certain exempons, the Ordinary Shares may not be offered to or sold within any Member State of the EEA, Canada, Japan or the Republic of South Africa or to any naonal, resident or cizen of any Member State of the EEA, Canada, Japan or the Republic of South Africa. Neither the Company nor Shore Capital, nor any of their respecve representaves, is making any representaon to any offeree or purchaser of the Ordinary Shares regarding the legality of an investment in the Ordinary Shares by such offeree or purchaser under the laws applicable to such offeree or purchaser. Each investor should consult with his or her own advisers as to the legal, tax, business, financial and related aspects of a purchase of the Ordinary Shares. None of the Company, the Investment Manager, Shore Capital, or any of their respecve affiliates, accepts any responsibility or liability whatsoever for, or makes any representaon or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the informaon in this announcement (or whether any informaon has been omied from the announcement) or any other informaon relang to the Company or associated companies, whether wrien, oral or in a visual or electronic form, and howsoever transmied or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connecon therewith. The Company, the Investment Manager, Shore Capital, and their respecve affiliates, accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement or its contents or otherwise arising in connecon therewith.